{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:52:38Z","timestamp":1771955558481,"version":"3.50.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ijcard.2014.10.026","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T22:02:43Z","timestamp":1413410563000},"page":"736-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Treatment of cachexia: An overview of recent developments"],"prefix":"10.1016","volume":"184","author":[{"given":"Stephan","family":"von Haehling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2014.10.026_bb0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13539-013-0124-8","article-title":"Cachexia vs obesity: where is the real unmet clinical need?","volume":"4","author":"von Haehling","year":"2013","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-012-0087-1","article-title":"Cancer cachexia: impact, mechanisms and emerging treatments","volume":"4","author":"Vaughan","year":"2013","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","article-title":"Cachexia as a major underestimated and unmet medical need: facts and numbers","volume":"1","author":"von Haehling","year":"2010","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13539-013-0105-y","article-title":"Cachexia as a major public health problem: frequent, costly, and deadly","volume":"4","author":"Farkas","year":"2013","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jamda.2011.04.014","article-title":"Sarcopenia with limited mobility: an international consensus","volume":"12","author":"Morley","year":"2011","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s13539-012-0089-z","article-title":"From muscle wasting to sarcopenia and myopenia: update 2012","volume":"3","author":"von Haehling","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13539-014-0156-8","article-title":"Sarcopenia: describing rather than defining a condition","volume":"5","author":"Alchin","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-011-0025-7","article-title":"Myopenia\u2014a new universal term for muscle wasting","volume":"2","author":"Fearon","year":"2011","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-014-0135-0","article-title":"Muscle wasting disease: a proposal for a new disease classification","volume":"5","author":"Anker","year":"2014","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s13539-011-0052-4","article-title":"Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass","volume":"3","author":"Sakuma","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s13539-014-0146-x","article-title":"Osteosarcopenic obesity: the role of bone, muscle, and fat on health","volume":"5","author":"Ormsbee","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13539-012-0062-x","article-title":"Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia","volume":"3","author":"Pedroso","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13539-011-0041-7","article-title":"Molecular control of neuromuscular junction development","volume":"3","author":"Ferraro","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13539-014-0149-7","article-title":"Are we closer to having drugs to treat muscle wasting disease?","volume":"5","author":"Morley","year":"2014","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jamda.2012.08.001","article-title":"Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review","volume":"14","author":"Malafarina","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2008.09.009","article-title":"Cardiac cachexia: a systematic overview","volume":"121","author":"von Haehling","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13539-011-0049-z","article-title":"Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance","volume":"3","author":"Busquets","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s13539-014-0139-9","article-title":"Attenuation of muscle wasting in murine C2C 12 myotubes by epigallocatechin-3-gallate","volume":"5","author":"Mirza","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13539-011-0044-4","article-title":"Ursodeoxycholic acid treatment in a rat model of cancer cachexia","volume":"3","author":"Tschirner","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s13539-012-0101-7","article-title":"Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia","volume":"4","author":"Der-Torossian","year":"2013","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13539-012-0064-8","article-title":"Is there a genetic cause of appetite loss?\u2014an explorative study in 1,853 cancer patients","volume":"3","author":"Solheim","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fphys.2014.00088","article-title":"Pancreatic cancer cachexia: a review of mechanisms and therapeutics","volume":"5","author":"Tan","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s13539-012-0082-6","article-title":"Anorexia\/cachexia of chronic diseases: a role for the TGF-\u03b2 family cytokine MIC-1\/GDF15","volume":"3","author":"Tsai","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0125","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jamda.2013.02.004","article-title":"Body weight, anorexia, and undernutrition in older people","volume":"14","author":"Soenen","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clnu.2013.01.004","article-title":"A new look at an old drug for the treatment of cancer cachexia: megestrol acetate","volume":"32","author":"Argil\u00e9s","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000346446","article-title":"Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide","volume":"58","author":"Wen","year":"2012","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0140","first-page":"1269","article-title":"Phase I\/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy","volume":"22","author":"Greig","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13539-011-0017-7","article-title":"l-Carnitine and cancer cachexia: clinical and experimental aspects","volume":"2","author":"Silv\u00e9rio","year":"2011","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0150","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clnu.2011.10.005","article-title":"Randomized phase III clinical trial of a combined treatment with carnitine+celecoxib\u00b1megestrol acetate for patients with cancer-related anorexia\/cachexia syndrome","volume":"31","author":"Madeddu","year":"2012","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2891-11-52","article-title":"L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) \u2014 a randomized multicentre trial","volume":"11","author":"Kraft","year":"2012","journal-title":"Nutr J"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0160","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/pbc.24828","article-title":"A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and\/or cancer therapy","volume":"61","author":"Cuvelier","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(00)02031-X","article-title":"Melatonin reversal of DOI-induced hypophagia in rats; possible mechanism by suppressing 5-HT(2A) receptor-mediated activation of HPA axis","volume":"860","author":"Raghavendra","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0170","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1200\/JCO.2012.43.6766","article-title":"Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial","volume":"31","author":"Del Fabbro","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0175","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1470-2045(14)70155-X","article-title":"MABp1, a first-in-class true human antibody targeting interleukin-1\u03b1 in refractory cancers: an open-label, phase 1 dose-escalation and expansion study","volume":"15","author":"Hong","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s002280100320","article-title":"Clinical pharmacology of thalidomide","volume":"57","author":"Eriksson","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0185","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/infdis\/168.2.408","article-title":"The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum","volume":"168","author":"Sampaio","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0190","first-page":"1059","article-title":"The role of thalidomide and placebo for the treatment of cancer-related anorexia\u2013cachexia symptoms: results of a double-blind placebo-controlled randomized study","volume":"15","author":"Yennurajalingam","year":"2012","journal-title":"J Palliat Care"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpainsymman.2011.03.007","article-title":"A phase II dose titration study of thalidomide for cancer-associated anorexia","volume":"43","author":"Davis","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13539-011-0019-5","article-title":"Wasting in chronic kidney disease","volume":"2","author":"Mak","year":"2011","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0205","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13539-013-0115-9","article-title":"Anti-inflammatory and anti-oxidative nutrition in hypoalbuminemic dialysis patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial","volume":"4","author":"Rattanasompattikul","year":"2013","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0210","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s13539-014-0162-x","article-title":"Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management","volume":"5","author":"Wakabayashi","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0215","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.biocel.2013.04.025","article-title":"Muscle wasting in heart failure: an overview","volume":"45","author":"von Haehling","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0220","first-page":"80","article-title":"Endocrine and metabolic activities of a recently isolated peptide hormone ghrelin, an endogenous ligand of the growth hormone secretagogue receptor","volume":"38","author":"Jarkovska","year":"2004","journal-title":"Endocr Regul"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0225","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13539-012-0074-6","article-title":"Molecular and cellular mechanisms of skeletal muscle atrophy: an update","volume":"3","author":"Fanzani","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13539-010-0011-5","article-title":"Ghrelin for cachexia","volume":"1","author":"Akamizu","year":"2010","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0235","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/cncr.21690","article-title":"Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients","volume":"106","author":"Wolf","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-012-0060-z","article-title":"Effect of sexual dimorphism on muscle strength in cachexia","volume":"3","author":"Norman","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0245","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13539-012-0065-7","article-title":"Hypogonadism in male cancer patients","volume":"3","author":"Burney","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0250","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13539-012-0085-3","article-title":"Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model","volume":"4","author":"Lenk","year":"2013","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13539-013-0103-0","article-title":"Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: the rationale and design of the Body Size in Stroke Study (BoSSS)","volume":"4","author":"Knops","year":"2013","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0260","first-page":"3949","article-title":"Decreased plasma ghrelin levels in patients with advanced cancer and weight loss in comparison to healthy individuals","volume":"29","author":"Legakis","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0265","first-page":"281","article-title":"The behaviour of the peptides leptin and ghrelin, PYY, NPY, CART and MSH in gastric cancer patients","volume":"3","author":"Barao","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0270","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s13539-012-0090-6","article-title":"Research on cachexia, sarcopenia and skeletal muscle in cardiology","volume":"3","author":"Coats","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0275","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","article-title":"Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure","volume":"110","author":"Nagaya","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0280","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1378\/chest.128.3.1187","article-title":"Treatment of cachexia with ghrelin in patients with COPD","volume":"128","author":"Nagaya","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0285","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1200\/jco.2007.25.18_suppl.9133","article-title":"A phase II, randomized, placebo-controlled, double blind study of the efficacy and safety of RC-1291 for the treatment of cancer-cachexia","volume":"25","author":"Garcia","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0290","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2003-031768","article-title":"Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial","volume":"89","author":"Neary","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0295","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.bjc.6604148","article-title":"Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia\/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study","volume":"98","author":"Strasser","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0300","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1681\/ASN.2005010039","article-title":"Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial","volume":"16","author":"Wynne","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0305","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ki.2009.114","article-title":"Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment","volume":"76","author":"Ashby","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0310","doi-asserted-by":"crossref","first-page":"e35708","DOI":"10.1371\/journal.pone.0035708","article-title":"Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"7","author":"Miki","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0315","first-page":"295","article-title":"Efficacy and safety results from a phase II study of anamorelin HCl, a ghrelin receptor agonist, in NSCLC patients","volume":"4","author":"Temel","year":"2013","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0320","first-page":"295","article-title":"Anamorelin HCl for the treatment of anorexia\u2013cachexia in lung cancer: study design and baseline characteristics of patients in the phase III clinical trial ROMANA 2 (HT-ANAM-302)","volume":"4","author":"Abernethy","year":"2013","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0325","first-page":"129","article-title":"Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study","volume":"21","author":"Garcia","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0330","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2009.04.078","article-title":"Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study","volume":"54","author":"Caminiti","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0335","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2010.03.090","article-title":"Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study","volume":"56","author":"Iellamo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0340","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","article-title":"Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)","volume":"34","author":"F\u00fclster","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0345","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","article-title":"Hormonal changes and catabolic\/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia","volume":"96","author":"Anker","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0350","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.2009.639","article-title":"Circulating estradiol and mortality in men with systolic chronic heart failure","volume":"301","author":"Jankowska","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0355","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13539-012-0061-y","article-title":"Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference","volume":"3","author":"Ebner","year":"2012","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0360","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.maturitas.2013.03.014","article-title":"Mechanism and novel therapeutic approaches to wasting in chronic disease","volume":"75","author":"Ebner","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0365","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","article-title":"The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial","volume":"2","author":"Dalton","year":"2011","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0370","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s13539-014-0161-y","article-title":"Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014","volume":"5","author":"Morley","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0375","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s13539-013-0114-x","article-title":"Type VI collagen turnover-related peptides\u2014novel serological biomarkers of muscle mass and anabolic response to loading in young men","volume":"4","author":"Nedergaard","year":"2013","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0380","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0385","first-page":"35","article-title":"A selective androgen receptor modulator (SARM), increases lean body mass (LBM) in advanced non-small cell lung cancer patients in two pivotal, international phase 3 trials","volume":"5","author":"Crawford","year":"2014","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0390","first-page":"2599","article-title":"Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial","volume":"21","author":"Del Fabbro","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0395","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13539-011-0046-2","volume":"24","author":"Stewart Coats","year":"2011","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0400","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13539-013-0125-7","article-title":"The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats","volume":"52","author":"P\u00f6tsch","year":"2014","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0405","first-page":"35","article-title":"Beta-blocker for the treatment of cancer cachexia: are they all equal?","volume":"5","author":"Palus","year":"2014","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0410","first-page":"35","article-title":"Espindolol for the treatment and prevention of cachexia in patients with stage III\/IV non-small cell lung cancer or colorectal cancer (ACT-ONE): randomised, double-blind, placebo-controlled, international multi-centre phase II study","volume":"5","author":"Coats","year":"2014","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2014.10.026_bb0415","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13539-014-0136-z","article-title":"Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies","volume":"5","author":"Ebner","year":"2014","journal-title":"J Cachex Sarcopenia Muscle"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314019548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314019548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:43:48Z","timestamp":1759092228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314019548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":83,"alternative-id":["S0167527314019548"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.10.026","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of cachexia: An overview of recent developments","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}